Sagini Micah N, Zepp Michael, Bergmann Frank, Bozza Matthias, Harbottle Richard, Berger Martin R
Toxicology and Chemotherapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
University Clinic of Heidelberg, Institute of Pathology, Heidelberg, Germany.
Genes Cancer. 2018 Mar;9(3-4):114-129. doi: 10.18632/genesandcancer.173.
Pancreatic adenocarcinoma is a highly aggressive malignancy with dismal prognosis and limited curative options. We investigated the influence of organ environments on gene expression in RNU rats by orthotopic and intraportal infusion of Suit2-007 cells into the pancreas, liver and lung respectively. Tumor tissues from these sites were analyzed by chip array and histopathology. Generated data was analyzed by Chipster and Ingenuity Pathway Analysis (±1.5 expression fold change and p<0.05). Further analysis of functional annotations derived from IPA, was based on selected genes with significant modulation of expression. Comparison of groups was performed by creating ratios from the mean expression values derived from pancreas and respective values, whereas those from liver and lung were related to pancreas, respectively. Genes of interest from three functional annotations for respective organs were identified by exclusion-overlap analyses. From the resulting six genes, transglutaminase2 (TGM2) was further investigated by various assays. Its knockdown with siRNA induced dose dependent inhibitory and stimulatory effects on cell proliferation and cell migration, respectively. DNA fragmentation indicated apoptotic cell death in response to TGM2 knockdown. Cell cycle analysis by FACS showed that TGM2 knockdown induced G1/S blockade. Therefore, TGM2 and its associated genes may be promising therapeutic targets.
胰腺腺癌是一种侵袭性很强的恶性肿瘤,预后很差,治愈选择有限。我们通过分别将Suit2-007细胞原位和门静脉内注入胰腺、肝脏和肺,研究了器官环境对RNU大鼠基因表达的影响。对这些部位的肿瘤组织进行芯片阵列和组织病理学分析。通过Chipster和 Ingenuity通路分析(表达倍数变化±1.5且p<0.05)对生成的数据进行分析。基于表达有显著调节的选定基因,对源自IPA的功能注释进行进一步分析。通过从胰腺获得的平均表达值与各自的值创建比率来进行组间比较,而肝脏和肺的比率分别与胰腺相关。通过排除重叠分析确定各器官三个功能注释中的感兴趣基因。从得到的六个基因中,通过各种试验对转谷氨酰胺酶2(TGM2)进行了进一步研究。用siRNA敲低TGM2分别对细胞增殖和细胞迁移诱导了剂量依赖性抑制和刺激作用。DNA片段化表明敲低TGM2会导致凋亡性细胞死亡。通过FACS进行的细胞周期分析表明,敲低TGM2会诱导G1/S期阻滞。因此,TGM2及其相关基因可能是有前景的治疗靶点。